CF PharmTech Surges 101% in Hong Kong Grey Market
View all comments(0)
Pharmaceutical manufacturer CF PharmTech surged 100.8% in Hong Kong grey market.

CF PharmTech reported revenue of nearly 610 million yuan last year, up 9% year-on-year. Its profit for the year totaled 21.09 million yuan, down 33.5%. Its first-quarter revenue this year reached 136 million yuan, down 2.7% year-over-year, while its profit for the period more than doubled to 12.82 million yuan.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Meta Connect 2026 New Product Roundup: Muse Integrated Into AI Glasses, Can It Drive Meta Revenue Growth?

Qualcomm Extends Long-Term Patent Agreement With Apple, Securing QTL Revenue in Era of In-House iPhone Modems

Oracle Tumbles 7% as Project Jupiter Data Center Force Majeure Notice Sparks Delay Concerns

Meta Stock Forecast: Muse Monetization Path Is Key as JPMorgan Raises Price Target to $920; Can Stock Hit Record High?

US Stocks Mixed as Dow Drops 160 Points; Tech Stocks Lead, Meta Rises 4.5%






Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.